- Home
- XLO vs DXLG Comparison
XLO vs DXLG Comparison
Compare XLO & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XLO | DXLG |
|---|---|---|
| Founded | 2016 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 38.2M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XLO | DXLG |
|---|---|---|
| Price | $8.68 | $0.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $28.00 | $1.50 |
| AVG Volume (30 Days) | ★ 264.1K | 199.4K |
| Earning Date | 03-23-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $43,766,000.00 | ★ $435,017,000.00 |
| Revenue This Year | $88.66 | $5.37 |
| Revenue Next Year | N/A | $4.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 589.88 | N/A |
| 52 Week Low | $0.46 | $0.46 |
| 52 Week High | $9.25 | $1.69 |
Technical Indicators
Market Signals| Indicator | XLO | DXLG |
|---|---|---|
| Relative Strength Index (RSI) | 88.43 | 41.56 |
| Support Level | $0.63 | N/A |
| Resistance Level | N/A | $0.57 |
| Average True Range (ATR) | 0.49 | 0.07 |
| MACD | 0.45 | 0.01 |
| Stochastic Oscillator | 90.56 | 7.77 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.